Ariel Berger
Evidera, part of PPD clinical research business of Thermo Fisher Scientific, United States
Executive Director, Integrated Solutions, Real-World Evidence
Ariel’s focus is database analytics where he designs and advises on various RWE and health economics studies, often involving complex methodologies and hybrid designs and disciplines. He has led numerous outcomes research studies, including retrospective database analyses; developed health economic models (budgetary impact and cost-effectiveness models); performed literature reviews; and prepared product dossiers. He has experience in a wide range of therapeutic areas and his work has been published in a variety of peer-reviewed journals and presented at numerous industry conferences. He has an MPH with a concentration in epidemiology and biostatistics from the Boston University School of Public Health and a BA from Syracuse University.
or sign up with email →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
